Your browser doesn't support javascript.
loading
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.
Chen, J S; Hsu, C; Chiang, N J; Tsai, C S; Tsou, H H; Huang, S F; Bai, L Y; Chang, I C; Shiah, H S; Ho, C L; Yen, C J; Lee, K D; Chiu, C F; Rau, K M; Yu, M S; Yang, Y; Hsieh, R K; Chang, J Y; Shan, Y S; Chao, Y; Chen, L T.
Afiliación
  • Chen JS; on behalf of the Taiwan Cooperative Oncology Group Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan.
  • Hsu C; Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei.
  • Chiang NJ; National Institute of Cancer Research, National Health Research Institutes, Tainan; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical Univers
  • Tsai CS; Division of Hematology and Oncology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan.
  • Tsou HH; Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Miaoli.
  • Huang SF; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli.
  • Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung.
  • Chang IC; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli.
  • Shiah HS; Taipei Cancer Center, Taipei Medical University Hospital, Taipei.
  • Ho CL; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, Taipei.
  • Yen CJ; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan.
  • Lee KD; Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi.
  • Chiu CF; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung.
  • Rau KM; Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung.
  • Yu MS; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung.
  • Yang Y; Division of Hematology and Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung.
  • Hsieh RK; Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei.
  • Chang JY; National Institute of Cancer Research, National Health Research Institutes, Tainan; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan.
  • Shan YS; Department of Surgery, National Cheng Kung University Hospital, Tainan.
  • Chao Y; Cancer Center, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical Univers
Ann Oncol ; 26(5): 943-949, 2015 May.
Article en En | MEDLINE | ID: mdl-25632066
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Desoxicitidina / Cetuximab / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Desoxicitidina / Cetuximab / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article